CIK 0001867066 · <br>Emerging growth company
Journey Medical Corp
Sign in to watch- Ticker
- DERM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471879539
- Phone
- 480-434-6670
- Business address
- 9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE, AZ, 85258
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-01 | Toledano Miranda Jayne Director | Grant or award | +50,000 | 168,618 | ||
| 2026-07-01 | Smith Justin Adam Director | Grant or award | +50,000 | 231,618 | ||
| 2026-07-01 | Herskowitz Neil Director | Grant or award | +50,000 | 168,618 | ||
| 2026-06-25 | Toledano Miranda Jayne Director | Grant or award | +10,000 | 118,618 | ||
| 2026-06-25 | Smith Justin Adam Director | Grant or award | +10,000 | 181,618 | ||
| 2026-06-25 | Herskowitz Neil Director | Grant or award | +10,000 | 118,618 | ||
| 2026-06-25 | Pearce Michael Cooper Director | Grant or award | +10,000 | 67,173 | ||
| 2026-06-25 | ROSENWALD LINDSAY A MD Director | Grant or award | +10,000 | 221,146 | ||
| 2026-04-22 | Alloush Ramsey Chief Operating Officer | Grant or award | +46,863 | 598,543 | ||
| 2026-04-22 | Alloush Ramsey Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +62,795 | 62,795 | ||
| 2026-04-22 | Benesch Joseph CFO | Grant or award | +28,907 | 261,371 | ||
| 2026-04-22 | Benesch Joseph CFO | Grant or award · Stock Option (Right to Buy) | +41,860 | 41,860 | ||
| 2026-04-22 | Maraoui Claude President & CEO | Grant or award | +49,277 | 2,435,990 | ||
| 2026-04-22 | Maraoui Claude President & CEO | Grant or award · Stock Option (Right to Buy) | +82,915 | 82,915 | ||
| 2025-08-25 | Maraoui Claude President & CEO | Option exercise | +1,250,000 | $0.07 | $81K | 2,397,590 |
| 2025-08-25 | Maraoui Claude President & CEO | Shares withheld for taxes | −10,877 | $7.47 | $81K | 2,386,713 |
| 2025-08-25 | Maraoui Claude President & CEO | Option exercise · Stock Option (Right to Buy) | −1,250,000 | 0 | ||
| 2025-08-05 | ROSENWALD LINDSAY A MD Director | Grant or award | +50,000 | 211,146 | ||
| 2025-08-05 | Smith Justin Adam Director | Grant or award | +20,000 | 171,618 | ||
| 2025-08-05 | Toledano Miranda Jayne Director | Grant or award | +20,000 | 108,618 |
Page 1 of 5 · 95 trades